Skip to main content
. 2018 Jul 20;84(10):2270–2279. doi: 10.1111/bcp.13668

Figure 1.

Figure 1

Pharmacokinetic properties of nangibotide. A: Mean and standard deviation (SD) blood concentration of nangibotide in a linear and log10 scale versus time. All subjects had no detectable nangibotide before treatment. B, C: Mean (+SD) maximum observed concentration following the loading dose (C max) and area under the blood concentration vs. time curve from time 0 to the last observation time (AUC0‐t) versus dose